Clinical Trial Update: Polycystic Ovarian Syndrome: Impact of Flaxseed Supplementation [Phase 2]

View source ↗

Summary

This update notes that a Phase 2 trial evaluating flaxseed supplementation for Polycystic Ovary Syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Flaxseed supplement (Linum usitatissimum seed supplement)

Snippet

Sponsor: Duke University | Conditions: Polycystic Ovarian Syndrome | Phase 2 | Status: TERMINATED